Cytokine and lipopolysaccharide stimulation of endothelin-1 release from human internal mammary artery and saphenous vein smooth-muscle cells.
Many pathologic conditions are associated with elevations in the production of endothelin-1 (ET-1) in the blood vessel wall. Because many of these conditions are cytokine-driven we examined the effects of a mixture of cytokines and lipopolysaccharide on ET-1 production in human vascular smooth-muscle (VSMC) cells derived from the internal mammary artery (IMA) and saphenous vein (SV). Incubation of VSMCs from IMA and SV with a combination of tumor necrosis factor-alpha (10 ng/ml), interferon-gamma (1,000 U/ml), interleukin-1 beta (500 U/ml) and lipopolysaccharide (10 micrograms/ml) for up to 48 h markedly elevated the expression of mRNA for ET-1 and the release of ET-1 into the culture medium. We conclude that low levels of ET-1 mRNA and peptide production in human VSMCs are markedly increased by exposure to cytokines and LPS. This suggests that during inflammatory states the VSMC, as well as the endothelium, may be a site of significant ET-1 production in the blood vessel wall.
Woods
M
M
William Harvey Research Institute, London, England.
Bishop-Bailey
D
D
Pepper
J R
JR
Evans
T W
TW
Mitchell
J A
JA
Warner
T D
TD
D002478:Cells, Cultured; D016207:Cytokines / Q000494:pharmacology*; D019332:Endothelin-1 / Q000378:metabolism*; D004731:Endotoxins / Q000494:pharmacology*; D005260:Female; D006801:Humans; D008070:Lipopolysaccharides / Q000494:pharmacology*; D008323:Mammary Arteries / Q000187:drug effects / Q000378:metabolism*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000378:metabolism*; D016133:Polymerase Chain Reaction; D012501:Saphenous Vein / Q000187:drug effects / Q000378:metabolism*; D013268:Stimulation, Chemical
D016207:Cytokines; D019332:Endothelin-1; D004731:Endotoxins; D008070:Lipopolysaccharides; C044101:endotoxin, Escherichia coli